비용적인 측면에서는 큰 차이는 없었으나 FC-SEMS군에서 스텐트 개존 기간이 길었으며 약물 치료 대기 시간이 짧았다.
There was no significant difference in terms of cost, but the stent patency period was longer and the waiting time for drug treatment was shorter in the FC-SEMS group.